Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate/Simvastatin vs Pravastatin in Mixed Dyslipidemia
NCT00362206Phase 3Completed
- Sponsor
- Solvay
- Start
- Sep 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of fenofibrate and simvastatin in mixed dyslipidemia (3 arms), sponsored by Solvay. Primary endpoints: Percent change in Triglycerides at 12 weeks, Percent change in HDL-C at 12 weeks and 1 more. Started Sep 2006; status: completed.
02
Drugs
fenofibratesimvastatin
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT00362206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00362206.